The monofunctional platinum(II) compounds, phenanthriplatin and pyriplatin, modulate apoptosis signaling pathways in HEI-OC1 auditory hybridoma cells.

Abstract

Cisplatin is a platinum(II) chemotherapy drug that can cause the side-effect of ototoxicity and hearing loss. The monofunctional platinum(II) complexes, phenanthriplatin and pyriplatin, have recently been investigated as anti-cancer agents but their side-effects are largely unknown. Here, we used the auditory hybridoma cell line, HEI-OC1, to investigate the ototoxicity of cisplatin, phenanthriplatin and pyriplatin. The effect of these compounds against cellular viability, on reactive oxygen species (ROS) production, mitochondrial membrane polarization, caspase-3/7 activity, DNA integrity and caspase-12 expression were measured using spectrophotometric, flow cytometric and blot analyses. We found that the monofunctional complexes and cisplatin decreased cellular viability. All three compounds increased ROS yield at 24 h, but at 48 h, ROS levels returned to normal. Also, the compounds did not depolarize the mitochondrial membrane. All three compounds reduced caspase-3/7 activity at 24 h; cisplatin increased caspase-3/7 activity and caused apoptosis at 48 h. Caspase-12 expression was associated with all three compounds. In summary, the monofunctional complexes may cause ototoxicity like cisplatin. Phenanthriplatin and pyriplatin may cause ototoxicity initially by inducing ROS production, but they may also signal through distinct apoptotic pathways that do not integrate caspases-3/7, or may act at different time-points in the same pathways.

• Authors: Jerry D Monroe, Alexandra M Johnston, Michael E Smith
• Journal: Neurotoxicology (Neurotoxicology) Vol. 79 Pg. 104-109 (07 2020) ISSN: 1872-9711 [Electronic] Netherlands
• PMID: 32413439 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
• Copyright: Copyright © 2020 Elsevier B.V. All rights reserved.

Chemical References

• Antineoplastic Agents
• Organoplatinum Compounds
• Phenanthridines
• Reactive Oxygen Species
• cis-diammine(pyridine)chloroplatinum(II)
• phenanthriplatin
• Casp12 protein, mouse
• Casp3 protein, mouse
• Casp7 protein, mouse
• Caspase 12
• Caspase 3
• Caspase 7
• Caspases

Topics

• Animals
• Antineoplastic Agents (toxicity)
• Apoptosis (drug effects)
• Caspase 12 (metabolism)
• Caspase 3 (metabolism)
• Caspase 7 (metabolism)
• Caspases (metabolism)
• Cell Line
• Cochlea (drug effects, metabolism, pathology)
• Hybridomas
• Mice
• Organoplatinum Compounds (toxicity)
• Ototoxicity
• Phenanthridines (toxicity)
• Reactive Oxygen Species (metabolism)
• Signal Transduction